Diaryl urea PI3K/mTOR/HDAC multi-target inhibitor as well as pharmaceutical composition and application thereof
The invention belongs to the technical field of medicines, and particularly relates to a diarylurea PI3K/mTOR/HDAC multi-target inhibitor as well as a pharmaceutical composition and application of the diarylurea PI3K/mTOR/HDAC multi-target inhibitor. The diarylurea PI3K/mTOR/HDAC multi-target inhibitor disclosed by the invention belongs to a single-molecule multi-target inhibitor, has multiple action mechanisms, and has the characteristics of good curative effect and small toxicity. The compound has the characteristic of effectively inhibiting a plurality of PI3K subtype kinases, mTOR kinases and HDAC proteins. The structure of the diarylurea PI3K/mTOR/HDAC multi-target inhibitor is as shown in the specification..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 12. Mai Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
ZHANG JIQUAN [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-05-12, Last update posted on www.tib.eu: 2023-10-31, Last updated: 2023-11-03 |
---|
Patentnummer: |
CN116102545 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA018336108 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA018336108 | ||
003 | DE-627 | ||
005 | 20231103090239.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231103s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA018336108 | ||
035 | |a (EPA)CN116102545 | ||
035 | |a (EPA)86253757 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a ZHANG JIQUAN |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diaryl urea PI3K/mTOR/HDAC multi-target inhibitor as well as pharmaceutical composition and application thereof |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-05-12, Last update posted on www.tib.eu: 2023-10-31, Last updated: 2023-11-03 | ||
520 | |a The invention belongs to the technical field of medicines, and particularly relates to a diarylurea PI3K/mTOR/HDAC multi-target inhibitor as well as a pharmaceutical composition and application of the diarylurea PI3K/mTOR/HDAC multi-target inhibitor. The diarylurea PI3K/mTOR/HDAC multi-target inhibitor disclosed by the invention belongs to a single-molecule multi-target inhibitor, has multiple action mechanisms, and has the characteristics of good curative effect and small toxicity. The compound has the characteristic of effectively inhibiting a plurality of PI3K subtype kinases, mTOR kinases and HDAC proteins. The structure of the diarylurea PI3K/mTOR/HDAC multi-target inhibitor is as shown in the specification. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a SUN QIWEN |4 aut | |
700 | 0 | |a WU CHUNFENG |4 aut | |
700 | 0 | |a MA DAN |4 aut | |
700 | 0 | |a TANG LEI |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 12. Mai |
773 | 1 | 8 | |g year:2023 |g day:12 |g month:05 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/86253757/publication/CN116102545A1?q=CN116102545 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 12 |c 05 |
951 | |a AR | ||
952 | |j 2023 |b 12 |c 05 |